The characterization of CD8⁺ T-cell responses in COVID-19

References

• WHO Coronavirus (COVID-19) Dashboard. Available from: https://covid19.who.int/?mapFilter=vaccinations.
   Google Scholar
• Sanyaolu A, Okorie C, Marinkovic A, et al. Current advancements and future prospects of COVID-19 vaccines and therapeutics: a narrative review. Ther Adv Vaccines Immunotherapy. 2022;10:251513552210975, doi:10.1177/25151355221097559. PubMed PMID: 35664358; PubMed Central PMCID: PMCPMC9160920. eng.
   Google Scholar
• Statement on the fifteenth meeting of the IHR. (2005). Emergency committee on the COVID-19 pandemic. Available from: https://www.who.int/zh/news/item/05-05-2023-statement-on-the-fifteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic.
   Google Scholar
• Mortezaee K, Majidpoor J. Cellular immune states in SARS-CoV-2-induced disease. Front Immunol. 2022;13:1016304, doi:10.3389/fimmu.2022.1016304. PubMed PMID: 36505442; PubMed Central PMCID: PMCPMC9726761. eng.
   PubMedGoogle Scholar
• Mallajosyula V, Ganjavi C, Chakraborty S, et al. CD8(+) T cells specific for conserved coronavirus epitopes correlate with milder disease in COVID-19 patients. Sci Immunol. 2021;6(61). doi:10.1126/sciimmunol.abg5669. PubMed PMID: 34210785; PubMed Central PMCID: PMCPMC8975171. eng.
   PubMed Web of Science ®Google Scholar
• Vardhana S, Baldo L, Morice WG, et al. Understanding T cell responses to COVID-19 is essential for informing public health strategies. Sci Immunol. 2022;7(71):eabo1303, doi:10.1126/sciimmunol.abo1303. PubMed PMID: 35324269; PubMed Central PMCID: PMCPMC10344642. eng.
   PubMed Web of Science ®Google Scholar
• Bergamaschi L, Mescia F, Turner L, et al. Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease. Immunity. 2021;54(6):1257–1275.e8. doi:10.1016/j.immuni.2021.05.010. PubMed PMID: 34051148; PubMed Central PMCID: PMCPMC8125900. eng.
   PubMed Web of Science ®Google Scholar
• Wagner KI, Mateyka LM, Jarosch S, et al. Recruitment of highly cytotoxic CD8(+) T cell receptors in mild SARS-CoV-2 infection. Cell Rep. 2022;38(2):110214, doi:10.1016/j.celrep.2021.110214. PubMed PMID: 34968416; PubMed Central PMCID: PMCPMC8677487. eng.
   PubMed Web of Science ®Google Scholar
• Grau-Expósito J, Sánchez-Gaona N, Massana N, et al. Peripheral and lung resident memory T cell responses against SARS-CoV-2. Nat Commun. 2021;12(1):3010, doi:10.1038/s41467-021-23333-3. PubMed PMID: 34021148; PubMed Central PMCID: PMCPMC8140108. eng.
   PubMed Web of Science ®Google Scholar
• Grifoni A, Weiskopf D, Ramirez SI, et al. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell. 2020;181(7):1489–1501.e15. doi:10.1016/j.cell.2020.05.015. PubMed PMID: 32473127; PubMed Central PMCID: PMCPMC7237901. eng.
   PubMed Web of Science ®Google Scholar
• Gao L, Zhou J, Yang S, et al. The dichotomous and incomplete adaptive immunity in COVID-19 patients with different disease severity. Sign Transduction Targeted Ther. 2021;6(1):113, doi:10.1038/s41392-021-00525-3. PubMed PMID: 33686064; PubMed Central PMCID: PMCPMC7938043. eng.
   PubMed Web of Science ®Google Scholar
• Spoerl S, Kremer AN, Aigner M, et al. Upregulation of CCR4 in activated CD8(+) T cells indicates enhanced lung homing in patients with severe acute SARS-CoV-2 infection. Eur J Immunol 2021;51(6):1436–1448. doi:10.1002/eji.202049135. PubMed PMID: 33784417; PubMed Central PMCID: PMCPMC8250120. eng.
   PubMed Web of Science ®Google Scholar
• Kared H, Redd AD, Bloch EM, et al. SARS-CoV-2-specific CD8+ T cell responses in convalescent COVID-19 individuals. J Clin Invest. 2021;131(5). doi:10.1172/jci145476. PubMed PMID: 33427749; PubMed Central PMCID: PMCPMC7919723. eng.
   PubMed Web of Science ®Google Scholar
• Kos I, Balensiefer B, Lesan V, et al. Increased B-cell activity with consumption of activated monocytes in severe COVID-19 patients. Eur J Immunol 2021;51(6):1449–1460. doi:10.1002/eji.202049163. PubMed PMID: 33788264; PubMed Central PMCID: PMCPMC8250224. eng.
   PubMed Web of Science ®Google Scholar
• Chen S, Guan F, Candotti F, et al. The role of B cells in COVID-19 infection and vaccination. Front Immunol. 2022;13:988536, doi:10.3389/fimmu.2022.988536. PubMed PMID: 36110861; PubMed Central PMCID: PMCPMC9468879. eng.
   PubMedGoogle Scholar
• Yu H, Guan F, Miller H, et al. The role of SARS-CoV-2 nucleocapsid protein in antiviral immunity and vaccine development. Emerg Microbes Infect. 2023;12(1):e2164219, doi:10.1080/22221751.2022.2164219. PubMed PMID: 36583642; PubMed Central PMCID: PMCPMC9980416. eng.
   PubMed Web of Science ®Google Scholar
• Costa PR, Correia CA, Marmorato MP, et al. Humoral and cellular immune responses to CoronaVac up to one year after vaccination. Front Immunol. 2022;13:1032411, doi:10.3389/fimmu.2022.1032411. PubMed PMID: 36341425; PubMed Central PMCID: PMCPMC9634255. eng.
   PubMedGoogle Scholar
• Sette A, Crotty S. Immunological memory to SARS-CoV-2 infection and COVID-19 vaccines. Immunol Rev 2022;310(1):27–46. doi:10.1111/imr.13089. PubMed PMID: 35733376; PubMed Central PMCID: PMCPMC9349657. eng.
   PubMed Web of Science ®Google Scholar
• Poon MML, Rybkina K, Kato Y, et al. SARS-CoV-2 infection generates tissue-localized immunological memory in humans. Sci Immunol. 2021;6(65):eabl9105, doi:10.1126/sciimmunol.abl9105. PubMed PMID: 34618554; PubMed Central PMCID: PMCPMC8626868. eng.
   PubMed Web of Science ®Google Scholar
• Niessl J, Sekine T, Lange J, et al. Identification of resident memory CD8(+) T cells with functional specificity for SARS-CoV-2 in unexposed oropharyngeal lymphoid tissue. Sci Immunol. 2021;6(64):eabk0894, doi:10.1126/sciimmunol.abk0894. PubMed PMID: 34519539; eng.
   PubMed Web of Science ®Google Scholar
• Peng Y, Mentzer AJ, Liu G, et al. Broad and strong memory CD4(+) and CD8(+) T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19. Nat Immunol 2020;21(11):1336–1345. doi:10.1038/s41590-020-0782-6. PubMed PMID: 32887977; PubMed Central PMCID: PMCPMC7611020. eng.
   PubMed Web of Science ®Google Scholar
• Keeton R, Tincho MB, Ngomti A, et al. T cell responses to SARS-CoV-2 spike cross-recognize Omicron. Nature. 2022;603(7901):488–492. doi:10.1038/s41586-022-04460-3. PubMed PMID: 35102311; PubMed Central PMCID: PMCPMC8930768. eng.
   PubMed Web of Science ®Google Scholar
• Adamo S, Michler J, Zurbuchen Y, et al. Signature of long-lived memory CD8(+) T cells in acute SARS-CoV-2 infection. Nature. 2022;602(7895):148–155. doi:10.1038/s41586-021-04280-x. PubMed PMID: 34875673; PubMed Central PMCID: PMCPMC8810382. eng.
   PubMed Web of Science ®Google Scholar
• Zhao J, Alshukairi AN, Baharoon SA, et al. Recovery from the Middle East respiratory syndrome is associated with antibody and T-cell responses. Sci Immunol. 2017;2(14). doi:10.1126/sciimmunol.aan5393. PubMed PMID: 28778905; PubMed Central PMCID: PMCPMC5576145. eng.
   PubMed Web of Science ®Google Scholar
• Maaske J, Sproule S, Falsey AR, et al. Robust humoral and cellular recall responses to AZD1222 attenuate breakthrough SARS-CoV-2 infection compared to unvaccinated. Front Immunol. 2022;13:1062067, doi:10.3389/fimmu.2022.1062067. PubMed PMID: 36713413; PubMed Central PMCID: PMCPMC9881590. eng.
   PubMed Web of Science ®Google Scholar
• Le Bert N, Tan AT, Kunasegaran K, et al. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature. 2020;584(7821):457–462. doi:10.1038/s41586-020-2550-z. PubMed PMID: 32668444; eng.
   PubMed Web of Science ®Google Scholar
• Peng K, Li X, Yang D, et al. Risk of autoimmune diseases following COVID-19 and the potential protective effect from vaccination: a population-based cohort study. EClinicalMedicine. 2023;63:102154, doi:10.1016/j.eclinm.2023.102154. PubMed PMID: 37637754; PubMed Central PMCID: PMCPMC10458663. eng.
   PubMedGoogle Scholar
• Abe N, Bohgaki M, Kasahara H. SARS-CoV-2 mRNA vaccination-induced autoimmune polyarthritis-like rheumatoid arthritis. Mayo Clin Proc 2022;97(8):1574–1575. doi:10.1016/j.mayocp.2022.06.001. PubMed PMID: 35933141; PubMed Central PMCID: PMCPMC9174152. eng.
   PubMed Web of Science ®Google Scholar
• Sher EK, Ćosović A, Džidić-Krivić A, et al. COVID-19 a triggering factor of autoimmune and multi-inflammatory diseases. Life Sci 2023;319:121531, doi:10.1016/j.lfs.2023.121531. PubMed PMID: 36858313; PubMed Central PMCID: PMCPMC9969758. eng.
   PubMed Web of Science ®Google Scholar
• Mohammadi B, Dua K, Saghafi M, et al. COVID-19-induced autoimmune thyroiditis: exploring molecular mechanisms. J Med Virol 2023;95(8):e29001, doi:10.1002/jmv.29001. PubMed PMID: 37515444; eng.
   PubMed Web of Science ®Google Scholar
• Zheng M. Autoreactive T cells of ankylosing spondylitis elicited by COVID-19 infection: a snapshot of immunological host defense and autoimmune imprinting. Autoimmun Rev. 2023;22(9):103392, doi:10.1016/j.autrev.2023.103392. PubMed PMID: 37455010; eng.
   PubMed Web of Science ®Google Scholar
• Lichtensteiger C, Koblischke M, Berner F, et al. Autoreactive T cells targeting type II pneumocyte antigens in COVID-19 convalescent patients. J Autoimmun 2023;140:103118, doi:10.1016/j.jaut.2023.103118. PubMed PMID: 37826919; eng.
   PubMed Web of Science ®Google Scholar
• Schulien I, Kemming J, Oberhardt V, et al. Characterization of pre-existing and induced SARS-CoV-2-specific CD8(+) T cells. Nat Med 2021;27(1):78–85. doi:10.1038/s41591-020-01143-2. PubMed PMID: 33184509; eng.
   PubMed Web of Science ®Google Scholar
• Swadling L, Diniz MO, Schmidt NM, et al. Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2. Nature. 2022;601(7891):110–117. doi:10.1038/s41586-021-04186-8. PubMed PMID: 34758478; PubMed Central PMCID: PMCPMC8732273. eng.
   PubMed Web of Science ®Google Scholar
• Kundu R, Narean JS, Wang L, et al. Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts. Nat Commun. 2022;13(1):80, doi:10.1038/s41467-021-27674-x. PubMed PMID: 35013199; PubMed Central PMCID: PMCPMC8748880. eng.
   PubMed Web of Science ®Google Scholar
• Diniz MO, Mitsi E, Swadling L, et al. Airway-resident T cells from unexposed individuals cross-recognize SARS-CoV-2. Nat Immunol 2022;23(9):1324–1329. doi:10.1038/s41590-022-01292-1. PubMed PMID: 36038709; PubMed Central PMCID: PMCPMC9477726. eng.
   PubMed Web of Science ®Google Scholar
• Cheon IS, Li C, Son YM, et al. Immune signatures underlying post-acute COVID-19 lung sequelae. Sci Immunol. 2021;6(65):eabk1741, doi:10.1126/sciimmunol.abk1741. PubMed PMID: 34591653; PubMed Central PMCID: PMCPMC8763087. eng.
   PubMed Web of Science ®Google Scholar
• Schmidt KG, Nganou-Makamdop K, Tenbusch M, et al. SARS-CoV-2-Seronegative subjects target CTL epitopes in the SARS-CoV-2 nucleoprotein cross-reactive to common cold coronaviruses. Front Immunol. 2021;12:627568, doi:10.3389/fimmu.2021.627568. PubMed PMID: 33995351; PubMed Central PMCID: PMCPMC8113865. eng.
   PubMed Web of Science ®Google Scholar
• Lineburg KE, Grant EJ, Swaminathan S, et al. CD8(+) T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses. Immunity. 2021;54(5):1055–1065.e5. doi:10.1016/j.immuni.2021.04.006. PubMed PMID: 33945786; PubMed Central PMCID: PMCPMC8043652. eng.
   PubMed Web of Science ®Google Scholar
• Lipsitch M, Grad YH, Sette A, et al. Cross-reactive memory T cells and herd immunity to SARS-CoV-2. Nat Rev Immunol. 2020;20(11):709–713. doi:10.1038/s41577-020-00460-4. PubMed PMID: 33024281; PubMed Central PMCID: PMCPMC7537578. eng.
   PubMed Web of Science ®Google Scholar
• Grifoni A, Voic H, Dhanda SK, et al. T cell responses induced by attenuated flavivirus vaccination are specific and show limited cross-reactivity with other flavivirus species. J Virol. 2020;94(10). doi:10.1128/jvi.00089-20. PubMed PMID: 32132233; PubMed Central PMCID: PMCPMC7199411. eng.
   Web of Science ®Google Scholar
• Lim JME, Tan AT, Le Bert N, et al. SARS-CoV-2 breakthrough infection in vaccinees induces virus-specific nasal-resident CD8 + and CD4+ T cells of broad specificity. J Exp Med 2022;219(10). doi:10.1084/jem.20220780. PubMed PMID: 35972472; PubMed Central PMCID: PMCPMC9386509. eng.
   Web of Science ®Google Scholar
• COVID-19 vaccine tracker and landscape: World Health Organization,; [updated 30 March 2023]. Available from: https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines.
   Google Scholar
• Fiolet T, Kherabi Y, MacDonald CJ, et al. Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review. Clin Microbiol Infect. 2022;28(2):202–221. doi:10.1016/j.cmi.2021.10.005. PubMed PMID: 34715347; PubMed Central PMCID: PMCPMC8548286. eng.
   PubMed Web of Science ®Google Scholar
• Heitmann JS, Bilich T, Tandler C, et al. A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity. Nature. 2022;601(7894):617–622. doi:10.1038/s41586-021-04232-5. PubMed PMID: 34814158; PubMed Central PMCID: PMCPMC8791831. eng.
   PubMed Web of Science ®Google Scholar
• Sahin U, Muik A, Derhovanessian E, et al. COVID-19 vaccine BNT162b1 elicits human antibody and T(H)1 T cell responses. Nature. 2020;586(7830):594–599. doi:10.1038/s41586-020-2814-7. PubMed PMID: 32998157; eng.
   PubMed Web of Science ®Google Scholar
• Chen J, Wang P, Yuan L, et al. A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2. Sci Bull. 2022;67(13):1372–1387. doi:10.1016/j.scib.2022.05.018. PubMed PMID: 35637645; PubMed Central PMCID: PMCPMC9134758. eng.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Mateus J, Coelho CH, et al. Humoral and cellular immune memory to four COVID-19 vaccines. Cell. 2022;185(14):2434–2451.e17. doi:10.1016/j.cell.2022.05.022. PubMed PMID: 35764089; PubMed Central PMCID: PMCPMC9135677. eng.
   PubMed Web of Science ®Google Scholar
• Wang CY, Hwang KP, Kuo HK, et al. A multitope SARS-CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variants. J Clin Invest. 2022;132(10). doi:10.1172/jci157707. PubMed PMID: 35316221; PubMed Central PMCID: PMCPMC9106357. eng.
   Web of Science ®Google Scholar
• Sahin U, Muik A, Vogler I, et al. BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans. Nature. 2021;595(7868):572–577. doi:10.1038/s41586-021-03653-6. PubMed PMID: 34044428; eng.
   PubMed Web of Science ®Google Scholar
• Zuo F, Abolhassani H, Du L, et al. Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant. Nat Commun. 2022;13(1):2670, doi:10.1038/s41467-022-30340-5. PubMed PMID: 35562366; PubMed Central PMCID: PMCPMC9106736. eng.
   PubMed Web of Science ®Google Scholar
• Akondy RS, Fitch M, Edupuganti S, et al. Origin and differentiation of human memory CD8 T cells after vaccination. Nature. 2017;552(7685):362–367. doi:10.1038/nature24633. PubMed PMID: 29236685; PubMed Central PMCID: PMCPMC6037316. eng.
   PubMed Web of Science ®Google Scholar
• Ssemaganda A, Nguyen HM, Nuhu F, et al. Expansion of cytotoxic tissue-resident CD8(+) T cells and CCR6(+)CD161(+) CD4(+) T cells in the nasal mucosa following mRNA COVID-19 vaccination. Nat Commun. 2023;14(1):3357, doi:10.1038/s41467-023-38887-7. PubMed PMID: 35688805; PubMed Central PMCID: PMCPMC9186487. eng.
   PubMedGoogle Scholar
• Afkhami S, D'Agostino MR, Zhang A, et al. Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2. Cell. 2022;185(5):896–915.e19. doi:10.1016/j.cell.2022.02.005. PubMed PMID: 35180381; PubMed Central PMCID: PMCPMC8825346. eng.
   PubMed Web of Science ®Google Scholar
• Sophonmanee R, Ongarj J, Seeyankem B, et al. T-Cell responses induced by an intradermal BNT162b2 mRNA vaccine booster following primary vaccination with inactivated SARS-CoV-2 vaccine. Vaccines (Basel). 2022;10(9). doi:10.3390/vaccines10091494. PubMed PMID: 36146571; PubMed Central PMCID: PMCPMC9501140. eng.
   PubMed Web of Science ®Google Scholar
• Oberhardt V, Luxenburger H, Kemming J, et al. Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine. Nature. 2021;597(7875):268–273. doi:10.1038/s41586-021-03841-4. PubMed PMID: 34320609; PubMed Central PMCID: PMCPMC8426185. eng.
   PubMed Web of Science ®Google Scholar
• Zhu FC, Li YH, Guan XH, et al. Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial. Lancet (London, England). 2020;395(10240):1845–1854. doi:10.1016/s0140-6736(20)31208-3. PubMed PMID: 32450106; PubMed Central PMCID: PMCPMC7255193. eng.
   PubMed Web of Science ®Google Scholar
• Tarke A, Coelho CH, Zhang Z, et al. SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron. Cell. 2022;185(5):847–859.e11. doi:10.1016/j.cell.2022.01.015. PubMed PMID: 35139340; PubMed Central PMCID: PMCPMC8784649. eng.
   PubMed Web of Science ®Google Scholar
• Tarke A, Sidney J, Methot N, et al. Impact of SARS-CoV-2 variants on the total CD4(+) and CD8(+) T cell reactivity in infected or vaccinated individuals. Cell Rep Med. 2021;2(7):100355, doi:10.1016/j.xcrm.2021.100355. PubMed PMID: 34230917; PubMed Central PMCID: PMCPMC8249675. eng.
   PubMedGoogle Scholar
• Calcoen B, Callewaert N, Vandenbulcke A, et al. High incidence of SARS-CoV-2 variant of concern breakthrough infections despite residual humoral and cellular immunity induced by BNT162b2 vaccination in healthcare workers: a long-term follow-up study in Belgium. Viruses. 2022;14(6). doi:10.3390/v14061257. PubMed PMID: 35746728; PubMed Central PMCID: PMCPMC9228150. eng.
   PubMed Web of Science ®Google Scholar
• Redd AD, Nardin A, Kared H, et al. Minimal crossover between mutations associated with Omicron variant of SARS-CoV-2 and CD8(+) T-Cell epitopes identified in COVID-19 convalescent individuals. mBio. 2022;13(2):e0361721, doi:10.1128/mbio.03617-21. PubMed PMID: 35229637; PubMed Central PMCID: PMCPMC8941890. eng.
   PubMed Web of Science ®Google Scholar
• Casado JL, Vizcarra P, Martín-Colmenarejo S, et al. Lower T cell response against SARS-CoV-2 variants of concern after mRNA vaccine and risk of breakthrough infections in people living with HIV. AIDS (London, England). 2023. doi:10.1097/qad.0000000000003504. PubMed PMID: 36779501; eng.
   PubMed Web of Science ®Google Scholar
• Bobrovitz N, Ware H, Ma X, et al. Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression. Lancet Infect Dis. 2023;23(5):556–567. doi:10.1016/s1473-3099(22)00801-5. PubMed PMID: 36681084; PubMed Central PMCID: PMCPMC10014083. eng.
   PubMed Web of Science ®Google Scholar
• Ahmed MIM, Diepers P, Janke C, et al. Enhanced spike-specific, but attenuated nucleocapsid-specific T cell responses upon SARS-CoV-2 breakthrough versus non-breakthrough infections. Front Immunol. 2022;13:1026473, doi:10.3389/fimmu.2022.1026473. PubMed PMID: 36582222; PubMed Central PMCID: PMCPMC9792977. eng.
   PubMed Web of Science ®Google Scholar
• Ishii H, Nomura T, Yamamoto H, et al. Neutralizing-antibody-independent SARS-CoV-2 control correlated with intranasal-vaccine-induced CD8(+) T cell responses. Cell Reports Medicine. 2022;3(2):100520, doi:10.1016/j.xcrm.2022.100520. PubMed PMID: 35233545; PubMed Central PMCID: PMCPMC8768424. eng.
   PubMedGoogle Scholar
• Benet S, Blanch-Lombarte O, Ainsua-Enrich E, et al. Limited humoral and specific T-cell responses after SARS-CoV-2 vaccination in PWH with poor immune reconstitution. J Infect Dis 2022;226(11):1913–1923. doi:10.1093/infdis/jiac406. PubMed PMID: 36200261; PubMed Central PMCID: PMCPMC9619620. eng.
   PubMed Web of Science ®Google Scholar
• Harrington P, Doores KJ, Radia D, et al. Single dose of BNT162b2 mRNA vaccine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) induces neutralising antibody and polyfunctional T-cell responses in patients with chronic myeloid leukaemia. Br J Haematol 2021;194(6):999–1006. doi:10.1111/bjh.17568. PubMed PMID: 34085278; PubMed Central PMCID: PMCPMC8239833. eng.
   PubMed Web of Science ®Google Scholar
• Azeem MI, Nooka AK, Shanmugasundaram U, et al. Impaired SARS-CoV-2 variant neutralization and CD8+ T-cell responses following 3 doses of mRNA vaccines in myeloma: correlation with breakthrough infections. Blood Cancer Discovery. 2023;4(2):106–117. doi:10.1158/2643-3230.BCD-22-0173. PubMed PMID: 36511813; PubMed Central PMCID: PMCPMC9975771. eng.
   PubMedGoogle Scholar
• Gao M, Liu Y, Guo M, et al. Regulatory CD4(+) and CD8(+) T cells are negatively correlated with CD4(+) /CD8(+) T cell ratios in patients acutely infected with SARS-CoV-2. J Leukoc Biol 2021;109(1):91–97. doi:10.1002/JLB.5COVA0720-421RR. PubMed PMID: 32930458; eng.
   PubMed Web of Science ®Google Scholar
• Lakhani S, Flavell RA. Caspases and T lymphocytes: a flip of the coin? Immunol Rev. 2003;193:22–30. doi:10.1034/j.1600-065x.2003.00046.x. PubMed PMID: 12752667; eng.
   PubMed Web of Science ®Google Scholar
• Rydyznski Moderbacher C, Ramirez SI, Dan JM, et al. Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity. Cell. 2020;183(4):996–1012.e19. doi:10.1016/j.cell.2020.09.038. PubMed PMID: 33010815; PubMed Central PMCID: PMCPMC7494270. eng.
   PubMed Web of Science ®Google Scholar
• Proietto D, Dallan B, Gallerani E, et al. Ageing curtails the diversity and functionality of nascent CD8(+) T cell responses against SARS-CoV-2. Vaccines (Basel). 2023;11(1). doi:10.3390/vaccines11010154. PubMed PMID: 36679999; PubMed Central PMCID: PMCPMC9867380. eng.
   PubMed Web of Science ®Google Scholar
• Varchetta S, Mele D, Oliviero B, et al. Unique immunological profile in patients with COVID-19. Cell Mol Immunol 2021;18(3):604–612. doi:10.1038/s41423-020-00557-9. PubMed PMID: 33060840; PubMed Central PMCID: PMCPMC7557230. eng.
   PubMed Web of Science ®Google Scholar
• Demaria O, Cornen S, Daëron M, et al. Harnessing innate immunity in cancer therapy. Nature. 2019;574(7776):45–56. doi:10.1038/s41586-019-1593-5. PubMed PMID: 31578484; eng.
   PubMed Web of Science ®Google Scholar
• Qin L, Duan X, Dong JZ, et al. The unreversible reduced but persistent activated NK and CD8(+) T cells in severe/critical COVID-19 during omicron pandemic in China. Emerg Microbes Infect. 2023;12(1):2208679, doi:10.1080/22221751.2023.2179357. PubMed PMID: 37102227; PubMed Central PMCID: PMCPMC10187090. eng.
   PubMed Web of Science ®Google Scholar
• Schultheiß C, Paschold L, Simnica D, et al. Next-generation sequencing of T and B cell receptor repertoires from COVID-19 patients showed signatures associated with severity of disease. Immunity. 2020;53(2):442–455.e4. doi:10.1016/j.immuni.2020.06.024. PubMed PMID: 32668194; PubMed Central PMCID: PMCPMC7324317. eng.
   PubMed Web of Science ®Google Scholar
• Ahern DJ, Ai Z, Ainsworth M, et al. A blood atlas of COVID-19 defines hallmarks of disease severity and specificity. Cell. 2022;185(5):916–938.e58. doi:10.1016/j.cell.2022.01.012. PubMed PMID: 35216673; PubMed Central PMCID: PMCPMC8776501. eng.
   PubMed Web of Science ®Google Scholar
• Shoukat MS, Foers AD, Woodmansey S, et al. Use of machine learning to identify a T cell response to SARS-CoV-2. Cell Rep Med. 2021;2(2):100192, doi:10.1016/j.xcrm.2021.100192. PubMed PMID: 33495756; PubMed Central PMCID: PMCPMC7816879. eng.
   PubMedGoogle Scholar
• Zhang B, Upadhyay R, Hao Y, et al. Multimodal single-cell datasets characterize antigen-specific CD8(+) T cells across SARS-CoV-2 vaccination and infection. Nat Immunol 2012;13(10):1725–1734. doi:10.1038/ni.2403. PubMed PMID: 37735591; PubMed Central PMCID: PMCPMC10522491. eng.
   Google Scholar
• Schreibing F, Hannani MT, Kim H, et al. Dissecting CD8+ T cell pathology of severe SARS-CoV-2 infection by single-cell immunoprofiling. Front Immunol. 2022;13:1066176, doi:10.3389/fimmu.2022.1066176. PubMed PMID: 36591270; PubMed Central PMCID: PMCPMC9800604. eng.
   PubMed Web of Science ®Google Scholar